CoChat

Genome‐Wide Association Study of NAFLD Using Electronic Health Records

Open access
Fairfield, Cameron J., Drake, Thomas M., Pius, Riinu, Bretherick, Andrew D., Campbell, Archie, Clark, David W., Fallowfield, Jonathan A., Hayward, Caroline, Henderson, Neil C., Joshi, Peter K., Mills, Nicholas L., Porteous, David J., Ramachandran, Prakash, Semple, Robert K., Shaw, Catherine A., Sudlow, Cathie L.M., Timmers, Paul R.H.J., Wilson, James F., Wigmore, Stephen J., Harrison, Ewen M., Spiliopoulou, Athina · 2022 · Hepatology Communications
Cited by 97

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

Genome‐wide association studies (GWAS) have identified several risk loci for nonalcoholic fatty liver disease (NAFLD). Previous studies have largely relied on small sample sizes and have assessed quantitative traits. We performed a case‐control GWAS in the UK Biobank using recorded diagnosis of NAFLD based on diagnostic codes recommended in recent consensus guidelines. We performed a GWAS of 4,761 cases of NAFLD and 373,227 healthy controls without evidence of NAFLD. Sensitivity analyses were performed excluding other co‐existing hepatic pathology, adjusting for body mass index (BMI) and adjusting for alcohol intake. A total of 9,723,654 variants were assessed by logistic regression adjusted for age, sex, genetic principal components, and genotyping batch. We performed a GWAS meta‐analysis using available summary association statistics. Six risk loci were identified ( P < 5*10 −8 ) (apolipoprotein E [ APOE ], patatin‐like phospholipase domain containing 3 [ PNPLA3 , transmembrane 6 superfamily member 2 [ TM6SF2 ], glucokinase regulator [ GCKR ], mitochondrial amidoxime reducing component 1 [ MARC1 ], and tribbles pseudokinase 1 [ TRIB1 ]). All loci retained significance in sensitivity analyses without co‐existent hepatic pathology and after adjustment for BMI. PNPLA3 and TM6SF2 remained significant after adjustment for alcohol (alcohol intake was known in only 158,388 individuals), with others demonstrating consistent direction and magnitude of effect. All six loci were significant on meta‐analysis. Rs429358 ( P = 2.17*10 −11 ) is a missense variant within the APOE gene determining ϵ4 versus ϵ2/ϵ3 alleles. The ϵ4 allele of APOE offered protection against NAFLD (odds ratio for heterozygotes 0.84 [95% confidence interval 0.78‐0.90] and homozygotes 0.64 [0.50‐0.79]). Conclusion: This GWAS replicates six known NAFLD‐susceptibility loci and confirms that the ϵ4 allele of APOE is associated with protection against NAFLD. The results are consistent with published GWAS using histological and radiological measures of NAFLD, confirming that NAFLD identified through diagnostic codes from consensus guidelines is a valid alternative to more invasive and costly approaches.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hep4.1805

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 22 references

Cited by

Metadata

Authors
Fairfield, C. J., Drake, T. M., Pius, R., Bretherick, A. D., Campbell, A., Clark, D. W., Fallowfield, J. A., Hayward, C., Henderson, N. C., Joshi, P. K., Mills, N. L., Porteous, D. J., Ramachandran, P., Semple, R. K., Shaw, C. A., Sudlow, C. L. M., Timmers, P. R. H. J., Wilson, J. F., Wigmore, S. J., Harrison, E. M., & Spiliopoulou, A.
Venue
Hepatology Communications
Published
2021-09-17
Volume
6
Issue
2
Pages
297-308
ISSN
2471-254X (ISSN-L)
OpenAlex
W3199436224
Cited by
97
References
22
FWCI
8.88
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.